At Biogen Idec, science and innovation don't stop in the research lab. Process sciences and manufacturing are crucial to the success of our mission. With patients counting on us to deliver quality medicines whenever and wherever needed, Biogen Idec operates a global drug supply network capable of meeting those needs.

Our capabilities for protein manufacturing are world class in quality and scale. Biogen Idec has expertise in protein expression in mammalian cells and in manufacturing across a range of biologics from monoclonal antibodies to interferon proteins. We also have process sciences capability for cell culture and downstream processing.

With one of the leading capacities for biologics manufacturing in the biotechnology industry, Biogen Idec operates multiple facilities around the globe. These facilities include a 250,000-square-foot large-scale manufacturing (LSM) plant in Research Triangle Park (RTP), North Carolina. The LSM has 90,000 liters of bioreactor capacity and is one of the largest biologic manufacturing facilities of its kind in the world. It has received industry recognition for its exceptional design, innovative modular construction methods, and strong safety record.

The company also operates small scale facilities in RTP and Cambridge, Massachusetts, and is in the process of licensing a second 90,000 liter capacity facility in Hillerod, Denmark. With 196,000 liters of bioreactor capacity, Biogen Idec can support its own growing pipeline of products, as well as the products of partners.